← Eichor
Study identifier: NCT06893939 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Limited Versus Extended Trophic Feeding (LET-FEED) Trial

Condition: Sepsis · Length of Stay · Mortality  ·  Sponsor: University of Washington

PhasePhase 3
Planned participants350
Who can joinAll sexes, 0 Hours to 36 Hours
Healthy volunteersYes

About this study

Study Hypothesis/Question In infants born very preterm, advancing enteral feeds after 24 hours from birth (limited trophic feeds) versus after 72 hours (extended trophic feeds) reduces the risk of all-cause late onset sepsis (LOS) without increasing the risk of other adverse outcomes. Study Design Type This is a multi-center, open-label, parallel-group, individual randomized controlled trial comparing two different trophic feeding regimens in preterm infants born between 25w0d and 31w6d. These infants will be randomly assigned to either the intervention group, receiving limited trophic feeding (20 to 25 mL/kg/day for one day) or the control group, receiving extended trophic feeding (20 to 25 mL/kg/day for three days) prior to advancing enteral feeds until full feeding volume (140 mL/kg/day) is achieved. Eligibility Criteria Preterm infants with gestational ages between 25 0/7 and 31 6/7 weeks and a birthweight of \<1500 grams who are admitted to six participating neonatal units will be eligible for inclusion. Infants with \<5th percentile for weight at birth, vasopressor use within first 24 hours of life major congenital/genetic anomalies affecting enteral feeding, growth, or mortality, and those with a terminal illness in which decisions to withhold or limit support have been made will be excluded. Infants of parents or legal guardians who are unable to provide consent within 36 hours of birth will also be excluded. Study Intervention/Methods Written parental informed con…

This description comes directly from the study's public registry record.

Talk to the study team

Gregory C Valentine, MD MED FAAP  ·  (206) 543-3200  ·  gcvalent@uw.edu

Ariel Salas, MD, MSPH  ·  asalas@uabmc.edu

Always discuss trial participation with your own doctor first.

Locations (6)

University of Alabama at BirminghamBirmingham, Alabama, United StatesNot Yet Recruiting
University of South FloridaTampa, Florida, United StatesNot Yet Recruiting
University of OklahomaOklahoma City, Oklahoma, United StatesNot Yet Recruiting
Baylor College of MedicineHouston, Texas, United StatesNot Yet Recruiting
University of WashingtonSeattle, Washington, United StatesNot Yet Recruiting
St. Joseph's Medical CenterTacoma, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06893939